Halladay Benjamin

Esperion Therapeutics, Inc. · Chief Financial Officer

Halladay Benjamin is listed in public filings as officer: Chief Financial Officer. This Halladay Benjamin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Esperion Therapeutics, Inc. (ESPR). Investors use Halladay Benjamin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Esperion Therapeutics, Inc.ESPR$1.9M713.6k sharesSellMar 17, 2026$17.4K6.4k shares$2.71--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Esperion Therapeutics, Inc.ESPR$540k221.3k sharesGrant / ExerciseMar 13, 2026$539.9K221.3k shares$2.44--
Esperion Therapeutics, Inc.ESPR--720k sharesGrant / ExerciseMar 13, 2026Disclosure amount unavailable247.4k shares----
Esperion Therapeutics, Inc.ESPR$1.7M467.5k sharesSellDec 17, 2025$26.9K7.3k shares$3.67--
Esperion Therapeutics, Inc.ESPR$1.3M474.9k sharesSellSep 17, 2025$19.8K7k shares$2.81--
Esperion Therapeutics, Inc.ESPR$529k474.5k sharesSellJul 17, 2025$1211 shares$1.12--
Esperion Therapeutics, Inc.ESPR$547k474.5k sharesSellJun 17, 2025$8.3K7.2k shares$1.15--
Esperion Therapeutics, Inc.ESPR$464k481.7k sharesSellApr 17, 2025$88 shares$0.964--
Esperion Therapeutics, Inc.ESPR$714k481.7k sharesSellMar 18, 2025$5.2K3.5k shares$1.48--
Esperion Therapeutics, Inc.ESPR$320k213k sharesGrant / ExerciseMar 14, 2025$319.5K213k shares$1.50--
Esperion Therapeutics, Inc.ESPR--485.2k sharesGrant / ExerciseMar 14, 2025Disclosure amount unavailable238k shares----
Esperion Therapeutics, Inc.ESPR$448k240.7k sharesSellFeb 19, 2025$2011 shares$1.86--
Esperion Therapeutics, Inc.ESPR$545k240.7k sharesSellJan 17, 2025$209 shares$2.27--
Esperion Therapeutics, Inc.ESPR$583k240.7k sharesSellDec 17, 2024$7.9K3.2k shares$2.42--